Colossal Biosciences made a surprise announcement Monday, claiming it had brought the dire wolf back from the dead, achieving ...

In this Health Kick Podcast, Tim Boreham sits down with AdAlta's Tim Oldham to discuss the company's recent pivot and ...

Venture capitalists are shifting funding towards startups with robust intellectual property, especially in foundational ...

Nebraska Sen. Pete Ricketts told reporters on Wednesday that he would not be signing onto Iowa Sen. Chuck Grassley’s bill ...

The Youth Entrepreneurship Expo 2025 took place on April 9 as part of the ongoing Bangladesh Investment Summit 2025 at the ...

In this week’s edition of InnovationRx, we look at the impact of tariffs on healthcare costs, pioneers of treating MS, AI for ...

The Trump administration’s effort to slash federal funding to universities has found its latest targets, with the government ...

Is the biotech job market improving in 2025? Explore the latest trends and opportunities in the industry after a challenging ...

Here are a few key lessons any leader can apply when guiding their business through uncertainty or after a reputational hit.

Gene therapy for cystic fibrosis is advancing fast. Explore key biotech players, clinical progress, and its potential to ...

Colossal Biosciences says it used novel gene-editing technology to alter gray wolf DNA to breed the animals. Dire wolves ...

Colossal Biosciences said it used ancient DNA from the extinct species to create three dire wolf pups named Romulus, Remus ...